have also driven the consolidation of service lines. The Leapfrog Group, a collection of corporations that spends considerably on the health care needs of its employees, encourages patients and insurers to shift care for certain procedures toward large-volume centers with demonstrated VORs. 5, 6 Similarly, Level 1 trauma centers have been shown to have better mortality, 10, 11, 32 and emergency transport patterns in the US have been shaped with this understanding. If a VOR exists in the management of patients with traumatic ICH, that evidence should be factored into policies and quality standards and should play a role in planning the initial emergency transport and subsequent interfacility transfer of these patients.
In addition to the VORs, a handful of studies have reported mixed results for VCRs. Some studies indicate that high-volume centers, especially academic and trauma centers, generate higher costs because of the increased complexity of cases and the burden of maintaining higher levels of resources and staff. 1, 25 Other studies suggest that high-volume centers can refine processes, which conserves resources and shortens the duration of stay, ultimately lowering costs. 16, 20, 26, 28, 29, 35, 36 Still other studies have found that this correlation is minor 23 or does not exist at all. 8 We hypothesized that a VOR would exist in the management of traumatic ICH and, specifically, that mortality would decline when facilities treated at least 6 cases per year. This cutoff was based on the hypothesis that 1 case every other month is the minimum volume necessary for an institution to maintain refined processes and experienced staff members. We also hypothesized that a VCR would exist such that the elevated levels of resources and staff available at large referral centers would be more costly but would also be associated with lower mortality rates. The purpose of our study was to test these hypotheses and ultimately inform regionalization and transfer policies by identifying meaningful thresholds for the volume of care necessary to ensure high-quality and costeffective care.
Methods
This study was conducted using data from the 2006 NIS, which is generated by the Agency for Health Care Research and Quality through the Healthcare Cost and Utilization Project (http://www.hcup-us.ahrq.gov/ nisoverview.jsp). The NIS includes all annual discharge data from 20% of US hospitals, which can be weighted to represent all US hospitals, generating national estimates. We identified cases using ICD-9 codes. Inclusion criteria required the presence of at least one of the following injury codes: 852. . These codes were chosen as inclusion criteria based on the relatively consistent and objective diagnoses of the associated conditions, diagnoses universally based on the presence of blood on head imaging. Other head injury codes, such as those representing diffuse axonal injury or contusion, are based on more subjective clinical judgment, which would introduce additional uncertainty into comparisons performed in this study. Transferred cases, either into or out of a hospital, were excluded because such cases would probably introduce a bias against centers accepting transfers, which typically involve relatively acute patients whose treatment has been delayed during interfacility transport. To test the hypothesis that outcomes improve when a hospital treats at least 6 cases per year, we divided the hospitals of the NIS data set into cohorts based on annual volume of traumatic head bleeds. The cohorts included hospitals treating < 6, 6-11, 12-23, 24-59, or 60+ cases in 2006.
The primary outcome was the relationship between mortality and center patient volume. Secondary outcomes were the relationships between cost and patient volume as well as between discharge status and patient volume. The NIS classifies discharges into 1 of 7 categories, each with a unique code: routine (1), transfer to short-term facility (2), other transfer including skilled nursing facility or intermediate care (5), discharged with home health care (6), left against medical advice (7), died in hospital (20) , or discharged alive to an unknown destination (99). We compiled these classifications into 4 categories: favorable discharges (1, 2, or 6), unfavorable living discharges (5), deaths (20) , and patients excluded from the study (7 and 99.) We considered all poor outcomes together, including unfavorable living discharges and deaths as previously described 12 as well as death independently. For each cohort of hospitals, we calculated the rates of fatality and of poor outcomes. We then compared rates for each group with rates for the cohort from the smallest-volume centers (< 6 cases per year) using logistic regression to produce adjusted odds ratios with corresponding 95% confidence intervals.
In our adjusted logistic regression analyses, we controlled for both demographic and clinical factors. Demographic factors included patient age, sex, geographical region, urbanicity, hospital teaching status, hospital size by bed number, hospital size by patient volume, and day of week for admission. Clinical factors included comorbidities, the presence of other severe head trauma, neurosurgical procedures performed, significant nonneurological injury, and severity of ICH ( Table 2 ). Severity of ICH was determined by combining patients with similar injuries into groups with similar AIS values. All codes in the range of 852.00-852.09 and 852.10-852.19 corresponded to an AIS score of either 3 or 5 and were separated on that basis. All other 852 codes corresponding to an AIS score of either 4 or 5 were separated in the following manner: 852.20-852.29, 852.30-852.39, 852.40-852.49, and 852.50-852.59. We excluded patients with trauma to other body regions as defined by the presence of an AIS score ≥ 3 to limit the impact of nonneurological injuries on death. Limiting our analysis to severe isolated neurological trauma ensured that the principal determinant of our primary and secondary outcomes was head trauma rather than multisystem trauma or injuries to other body regions.
To determine the potential impact of this VOR on outcomes across the US, we estimated the number of lives that could have been saved if all patients were treated at facilities treating more than 6 cases per year. We calculated potential lives saved as the number of patients treated at small centers (< 6) multiplied by the difference between the mortality rate observed at those small centers and the average mortality rate of larger centers.
To test the hypothesis that the management of traumatic ICH is more expensive at larger centers, we looked at the average cost per case, which was determined by multiplying reported charges by either the specific hospital's or, when not available, the hospital group's average cost-to-charge ratio. The calculated cost for the hospital cohort managing fewer than 6 cases was then compared with the costs for the other 4 cohorts. Similarly, the average LOS in patients with traumatic ICH at the hospitals in each cohort was calculated and used to compare the cohort managing fewer than 6 cases with the other 4 hospital cohorts. These cost and LOS calculations were adjusted for the same demographic and clinical factors described above when comparing outcomes.
All statistical analyses were conducted using SAScallable SUDAAN, Release 10.0.1, 2011 (Research Triangle Institute) An a-level of 0.05 was considered necessary for statistical significance.
Results
The cohort of hospitals treating fewer than 6 cases of traumatic ICH in 2006 cared for approximately 2714 patients across the US (weighted based on 556 patients treated at 299 different centers in the NIS data set). The estimated case volumes of the other cohorts ranged from 2253 patients (weighted based on 462 patients treated at 64 centers) in the cohort of hospitals treating 6-11 cases per year to 37,372 patients (weighted based on 7661 patients treated at 79 centers) in the cohort treating 60+ cases per year (Table 3) .
Mortality was 14.9% in the cohort of very-small-volume centers (< 6 cases per year) and fell dramatically at larger centers, with rates of 8.0%, 8.3%, 9.5%, and 10.0%, respectively, at centers managing 6-11,12-23, 24-59, and 60+ cases in 2006. The overall rate of poor outcomes, defined to include death or any unfavorable living disposition, was 51.4% in the cohort of centers managing fewer than 6 cases per year and fell among the other cohorts to 45.3%, 47.3%, 44.8%, and 40.4%, respectively (Fig. 1) .
The relatively high mortality rate observed in the cohort of very-small-volume centers was significantly different from each of the respective mortality rates observed in the other 4 cohorts (after adjusting for demographic and clinical factors), with ORs ranging from 0.45 to 0.63 (Table 3) . After adjusting for the same demographic and clinical factors, the rate of poor outcomes observed among very-small-volume centers was significantly different only from the cohort of hospitals treating 6-11 cases per year.
We sought to determine the potential impact of this VOR, calculated as the lives that might have been saved if the 2714 patients (weighted based on 556 cases in the 2006 NIS data set) treated at very-small-volume centers had instead been treated at larger-volume centers. By re- distributing these patients among larger centers proportionally (relative to the patient volumes depicted in Table  3 ) and adjusting for the aforementioned factors, we calculated an approximate 37% decrease in mortality, or an estimated 150 lives saved. We observed an increase in the estimated actual costs as the hospital case volume rose. Hospitals treating fewer than 6 cases annually had an average cost of $7,802 per case, whereas those seeing 60+ cases had a cost of $16,422 per case (Table 3 ). However, after adjusting for demographic and clinical factors, there was not a significant difference in the average cost per case between the hospital cohort seeing fewer than 6 cases annually as compared with any of the busier groups of facilities. There was little difference in the raw average LOS (days), ranging from 4.8-7.1 days for the 5 cohorts. After adjusting for demographic and clinical factors, the differences in LOS did not reach statistical significance.
Discussion
Our findings support our hypothesis that a VOR exists in neurotrauma care and, specifically, that a threshold effect seems to exist such that outcomes improve when centers treat at least 1 case every other month. This finding is significant because it is being described both for the first time and in a data set that is specifically designed to generate national estimates, and thus we believe that our results are generalizable. The threshold effect we mention occurs at a relatively low volume. Although in some fields the crucial threshold occurs at large volumes, this is not always the case. For example, Nathens and Maier 31 reported that mortality benefits in trauma care are most prominent at centers managing over 650 cases per year. In other medical fields, hospitals or individual providers reach a meaningful cutoff with relatively low numbers. For instance, Birkmeyer et al. 7 demonstrated survival improvements after only 1 annual case for pancreatectomy, 2 for esophagectomy, and 3 for cystectomy. Our results suggest that the most relevant threshold is relatively low in the field of neurotrauma: survival is superior at centers treating 6 or more cases per year. The underlying reason, ¶ Cost compared to centers with < 6 cases/year (after covariate adjustment). we suspect, is that institutions reaching this volume are better able to develop and maintain refined processes and provider experience, leading to improved mortality.
Most VOR studies to date have reported continuous improvements in mortality with increasing patient volume. Birkmeyer and colleagues 7 showed that the mortality for 14 complex high-risk procedures generally continues to improve as a center adds volume. Our results, however, suggest that the mortality benefits of volume appear to plateau after only 6 cases per year in the treatment of traumatic ICH. Above this threshold, the observed fatality rate drops precipitously from 14.9% to a range of 8.0%-10.0% for the remaining groups (after adjustment for demographic and clinical factors).
Beyond the threshold of 6 cases per year, there was also a trend toward increased rates of favorable dispositions (patients discharged either home or to a short-term care facility) among larger centers. While not statistically significant after adjustments, this figure rose from 48.6% to 59.6% with increasing volume. It is possible that while maximum survival benefits can be attained with a modest volume of 6 cases per year, perhaps large centers bestow benefits other than survival. That is, smaller facilities discharge a greater proportion of patients to long-term care facilities, which we used as a proxy for poor functional outcomes. It should be mentioned that the relatively high acuity of cases managed at very large centers could be masking a further mortality or outcome benefit associated with high patient volumes given the complexity of statistical adjustments for case severity. However, considering the rigorous adjustments used in this analysis and the robust nature of the threshold detected, we suspect that even if a further mortality benefit is associated with very large centers, the effect is much less dramatic than the threshold of 6 cases per year reported here. Future studies with higher power, for example, multiyear NIS studies, could better illuminate the impact that very large centers have on functional outcomes among surviving patients.
The recognition of VORs in other fields of health care has led to the development of public policies as well as privately published guidelines, such as those produced by the Leapfrog Group, aimed at shifting care toward larger centers. Grumbach et al. 17 estimated in 1995 that regionalization policies in New York had shifted 60% of all CABG cases to high-volume centers versus 24% in areas without similar policies. Birkmeyer and Dimick 5 estimated that full implementation of the Leapfrog Group volume standards throughout the US could have averted 7818 deaths in 2000, including 4089 deaths following CABG and 3016 deaths following percutaneous coronary interventions. In 2006, there were approximately 2714 traumatic ICH patients in the US (weighted estimate based on 556 patients in the 2006 NIS data set) treated at very-small-volume centers (< 6 cases per year). Based on our adjusted multivariate models, shifting care to larger centers would have saved an estimated 150 lives. However, this shift can, in some cases, be a trade-off between the marginal outcome improvements seen at larger-volume centers versus the extra time spent delivering the patient. Thus, in the case of remote low-volume centers, it is unlikely that all neurotrauma patients could currently be diverted to larger-volume centers in a time-sensitive manner. In many areas, however, prehospital transport times could be minimized by instituting destination protocols that favor large centers rather than interfacility transfers.
Our findings do not support our hypothesis that a VCR exists in neurotrauma care. Despite a trend toward increased costs at very-large-volume centers relative to those seeing fewer than 6 cases per year (p = 0.11), the cost of care was not significantly different at low-volume as compared with high-volume centers. This result resembles findings in a handful of prior studies. 8, 23 Conversely, several previous studies have demonstrated a negative correlation between high volumes and relatively low costs for cardiac procedures, 23 esophagectomy, 29, 36 colorectal surgery, 20, 22 and pancreatic resection. 35 In our analysis, LOS, a major determinant of the cost of care, did not differ significantly with patient volume.
This study has a number of limitations. First, our sample size was potentially limited in certain calculations because we incorporated only 1 year of NIS data; this may have increased our risk of a Type 2 error. Second, for a handful of calculations, our use of odds ratios as proxies for relative risk may have been imprecise given the high prevalence of the measured variable, such as the rates of favorable discharges or poor outcomes, which ranged from 40%-60%. Third, some authors have suggested that surgeon volume is actually a more important determinant of outcomes 9, 34 and cost 22 than is hospital volume, whereas others have argued that greater patient volumes help hospitals learn to refine processes and management techniques. 18 In reality, both of these perspectives probably have some validity, and the familiarity of individual surgeons with emergent craniotomies would be expected to influence outcomes. Moreover, a surgeon's volume of elective craniotomy cases is also likely to impact performance during similar emergency procedures. However, we considered only hospital volumes of emergent craniotomies in our study. Still, this limitation seems justifiable, as traumatic ICH, a complex disease process requiring well-coordinated multidisciplinary care, is probably disproportionately affected by hospital processes and management techniques. Fourth, the NIS does not include physiology data, so we were unable to control for physiological parameters, a major predictor of outcome in neurotrauma. Fifth, other authors have acknowledged the importance of considering multiple quality metrics rather than volume alone when stratifying hospitals. 5 Here, we consider only volume, but the dramatic impact of volume observed in this study suggests that policies based on volume alone can have a powerful and beneficial impact on outcomes.
Conclusions
In summary, a VOR exists among hospitals managing traumatic ICH, with centers treating at least 6 cases per year demonstrating significantly lower mortality rates. The cost of care does not differ significantly between small and large centers. Thus, regionalization policies that shift cases away from low-volume centers can be expected to improve outcomes in this isolated example.
There are a number of levers that can be pulled to achieve this goal, including emergency transport patterns, interfacility transfer policies, regulations controlling future hospital construction, and guidelines encouraging patients and providers to shift care toward larger facilities.
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